Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Vectors | 42 | 2016 | 1837 | 2.530 |
Why?
|
| Adenoviruses, Human | 14 | 2013 | 191 | 1.710 |
Why?
|
| Adenoviridae | 38 | 2016 | 1490 | 1.710 |
Why?
|
| Capsid Proteins | 13 | 2010 | 219 | 1.310 |
Why?
|
| Genetic Therapy | 25 | 2016 | 1715 | 1.060 |
Why?
|
| Gene Targeting | 8 | 2010 | 312 | 0.840 |
Why?
|
| Gene Transfer Techniques | 22 | 2013 | 800 | 0.810 |
Why?
|
| Capsid | 8 | 2009 | 177 | 0.680 |
Why?
|
| Receptors, Virus | 16 | 2005 | 152 | 0.500 |
Why?
|
| Transduction, Genetic | 7 | 2007 | 493 | 0.460 |
Why?
|
| Genetic Engineering | 3 | 2003 | 288 | 0.420 |
Why?
|
| Adenoviruses, Simian | 1 | 2010 | 5 | 0.360 |
Why?
|
| Virion | 6 | 2010 | 185 | 0.270 |
Why?
|
| CD40 Antigens | 2 | 2003 | 107 | 0.270 |
Why?
|
| Oligopeptides | 10 | 2005 | 450 | 0.260 |
Why?
|
| Ligands | 7 | 2007 | 1007 | 0.250 |
Why?
|
| Bacteriophage T4 | 2 | 2003 | 9 | 0.250 |
Why?
|
| Enterovirus | 4 | 2002 | 57 | 0.250 |
Why?
|
| Integrins | 6 | 2005 | 273 | 0.240 |
Why?
|
| Luciferases | 9 | 2010 | 454 | 0.230 |
Why?
|
| Disulfides | 1 | 2003 | 111 | 0.220 |
Why?
|
| Viral Proteins | 3 | 2003 | 478 | 0.210 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 11 | 2005 | 40 | 0.210 |
Why?
|
| Cell Line | 10 | 2009 | 5313 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 21 | 2004 | 5759 | 0.190 |
Why?
|
| DNA, Viral | 2 | 2010 | 748 | 0.190 |
Why?
|
| ErbB Receptors | 5 | 2011 | 2376 | 0.180 |
Why?
|
| Virus Replication | 9 | 2008 | 762 | 0.160 |
Why?
|
| Epitopes | 3 | 2009 | 699 | 0.160 |
Why?
|
| Peptides | 3 | 2009 | 1502 | 0.150 |
Why?
|
| Liver | 9 | 2010 | 3058 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2009 | 1623 | 0.140 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 160 | 0.140 |
Why?
|
| Amino Acid Sequence | 10 | 2009 | 4532 | 0.130 |
Why?
|
| Isoenzymes | 3 | 2004 | 644 | 0.120 |
Why?
|
| Ankyrin Repeat | 2 | 2013 | 13 | 0.120 |
Why?
|
| Base Sequence | 7 | 2010 | 5405 | 0.120 |
Why?
|
| Genes, bcl-2 | 3 | 1999 | 172 | 0.120 |
Why?
|
| Mice | 23 | 2016 | 35420 | 0.120 |
Why?
|
| Animals | 29 | 2016 | 61350 | 0.110 |
Why?
|
| Ovarian Neoplasms | 9 | 2005 | 4810 | 0.110 |
Why?
|
| Molecular Sequence Data | 9 | 2009 | 6638 | 0.110 |
Why?
|
| HeLa Cells | 7 | 2005 | 1683 | 0.110 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 231 | 0.110 |
Why?
|
| Transfection | 7 | 2004 | 3109 | 0.110 |
Why?
|
| Recombinant Proteins | 5 | 2013 | 2986 | 0.100 |
Why?
|
| Protein Engineering | 1 | 2013 | 97 | 0.100 |
Why?
|
| Serotyping | 2 | 2010 | 185 | 0.100 |
Why?
|
| Dendritic Cells | 3 | 2004 | 1104 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 3 | 2013 | 2658 | 0.100 |
Why?
|
| Humans | 52 | 2016 | 270709 | 0.100 |
Why?
|
| Cell Line, Transformed | 3 | 2001 | 426 | 0.090 |
Why?
|
| Ice Cover | 1 | 2010 | 4 | 0.090 |
Why?
|
| Viral Tropism | 1 | 2010 | 41 | 0.090 |
Why?
|
| Factor X | 1 | 2010 | 10 | 0.090 |
Why?
|
| Kupffer Cells | 1 | 2010 | 41 | 0.090 |
Why?
|
| Mice, Nude | 10 | 2011 | 4332 | 0.090 |
Why?
|
| Species Specificity | 2 | 2010 | 783 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 233 | 0.090 |
Why?
|
| Single-Chain Antibodies | 1 | 2009 | 61 | 0.080 |
Why?
|
| Cell Line, Tumor | 10 | 2013 | 14885 | 0.080 |
Why?
|
| Thymidine Kinase | 2 | 2002 | 223 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2011 | 186 | 0.080 |
Why?
|
| Apoptosis | 6 | 2008 | 7757 | 0.080 |
Why?
|
| Plasmids | 5 | 2004 | 923 | 0.080 |
Why?
|
| Oncolytic Virotherapy | 2 | 2008 | 239 | 0.080 |
Why?
|
| Neoplasms | 2 | 2007 | 15951 | 0.080 |
Why?
|
| beta-Lipotropin | 1 | 1987 | 1 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 1489 | 0.070 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 92 | 0.070 |
Why?
|
| Tropism | 3 | 2004 | 18 | 0.070 |
Why?
|
| Immunoglobulin Fragments | 2 | 2003 | 25 | 0.070 |
Why?
|
| Genes, Viral | 2 | 2005 | 247 | 0.070 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1987 | 101 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 501 | 0.070 |
Why?
|
| Neoplasm Proteins | 3 | 2008 | 3345 | 0.070 |
Why?
|
| Receptors, Vitronectin | 2 | 2002 | 28 | 0.060 |
Why?
|
| Gene Expression | 7 | 2004 | 3606 | 0.060 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2005 | 35 | 0.060 |
Why?
|
| Sulfotransferases | 2 | 1995 | 42 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2010 | 7053 | 0.060 |
Why?
|
| Cytokines | 3 | 2010 | 2803 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 7 | 2005 | 3205 | 0.060 |
Why?
|
| Flow Cytometry | 7 | 2005 | 3040 | 0.060 |
Why?
|
| Escherichia coli | 5 | 2013 | 1286 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2003 | 5605 | 0.060 |
Why?
|
| Recombination, Genetic | 3 | 2003 | 649 | 0.060 |
Why?
|
| Complement C3 | 1 | 2004 | 80 | 0.060 |
Why?
|
| Staphylococcal Protein A | 1 | 2003 | 16 | 0.060 |
Why?
|
| Lung Neoplasms | 7 | 2011 | 12041 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 1999 | 4148 | 0.060 |
Why?
|
| Genes, Reporter | 5 | 2004 | 813 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2010 | 1217 | 0.060 |
Why?
|
| Herpesvirus 1, Human | 1 | 2004 | 115 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2003 | 509 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2003 | 130 | 0.050 |
Why?
|
| Adenoviridae Infections | 1 | 2003 | 114 | 0.050 |
Why?
|
| Protein Binding | 4 | 2013 | 3472 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2004 | 196 | 0.050 |
Why?
|
| Blotting, Western | 5 | 2011 | 3567 | 0.050 |
Why?
|
| Hepatitis C Antibodies | 1 | 2002 | 49 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2013 | 1736 | 0.050 |
Why?
|
| Adenovirus E1A Proteins | 4 | 2004 | 165 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2005 | 1503 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2005 | 489 | 0.050 |
Why?
|
| Gamma Cameras | 1 | 2002 | 38 | 0.050 |
Why?
|
| Receptors, Somatostatin | 1 | 2002 | 94 | 0.050 |
Why?
|
| Binding, Competitive | 3 | 2011 | 327 | 0.050 |
Why?
|
| Cricetinae | 1 | 2002 | 744 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 1469 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2002 | 192 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 2003 | 931 | 0.050 |
Why?
|
| Mesoderm | 1 | 2003 | 391 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 4103 | 0.050 |
Why?
|
| Ascitic Fluid | 1 | 2000 | 84 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2004 | 880 | 0.040 |
Why?
|
| Virus Assembly | 1 | 2000 | 54 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2000 | 337 | 0.040 |
Why?
|
| Integrin alpha3beta1 | 1 | 1999 | 6 | 0.040 |
Why?
|
| Receptors, Collagen | 1 | 1999 | 11 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2008 | 1435 | 0.040 |
Why?
|
| Membrane Proteins | 3 | 2004 | 2922 | 0.040 |
Why?
|
| Adenocarcinoma | 3 | 2004 | 7920 | 0.040 |
Why?
|
| Ascites | 1 | 2000 | 212 | 0.040 |
Why?
|
| Tissue Preservation | 1 | 1999 | 27 | 0.040 |
Why?
|
| DNA | 1 | 1987 | 3041 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 1127 | 0.040 |
Why?
|
| Organ Preservation | 1 | 1999 | 45 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 5157 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2000 | 527 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 1999 | 143 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1581 | 0.040 |
Why?
|
| Spodoptera | 1 | 1998 | 81 | 0.040 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 299 | 0.040 |
Why?
|
| Baculoviridae | 1 | 1998 | 109 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2003 | 503 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2003 | 506 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2008 | 1781 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 3 | 2005 | 496 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 2001 | 342 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2002 | 548 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2000 | 822 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2004 | 686 | 0.040 |
Why?
|
| Time Factors | 7 | 2004 | 12974 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2011 | 5582 | 0.030 |
Why?
|
| Cloning, Molecular | 3 | 2003 | 1406 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2004 | 596 | 0.030 |
Why?
|
| Female | 18 | 2010 | 148873 | 0.030 |
Why?
|
| Biogenic Monoamines | 1 | 1995 | 8 | 0.030 |
Why?
|
| Arylsulfotransferase | 1 | 1995 | 20 | 0.030 |
Why?
|
| Stomach Neoplasms | 2 | 2005 | 2339 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 2003 | 5258 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2004 | 6344 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1999 | 863 | 0.030 |
Why?
|
| Glioma | 2 | 2003 | 1986 | 0.030 |
Why?
|
| Brain Neoplasms | 2 | 2008 | 4971 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2005 | 197 | 0.030 |
Why?
|
| Lac Operon | 2 | 2004 | 133 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2011 | 3929 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 136 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 1544 | 0.030 |
Why?
|
| Myocardium | 1 | 1998 | 1180 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 1553 | 0.030 |
Why?
|
| Transgenes | 2 | 2004 | 568 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 1995 | 425 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 9048 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 2005 | 3328 | 0.020 |
Why?
|
| Radiopharmaceuticals | 2 | 2011 | 1342 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 631 | 0.020 |
Why?
|
| Estradiol | 1 | 1995 | 828 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2004 | 590 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2004 | 3241 | 0.020 |
Why?
|
| Technetium | 2 | 2002 | 79 | 0.020 |
Why?
|
| Peptide Library | 1 | 2010 | 148 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 2009 | 40 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1999 | 1188 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2002 | 2392 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2003 | 1050 | 0.020 |
Why?
|
| Antibodies | 2 | 2005 | 801 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 651 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2009 | 231 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1458 | 0.020 |
Why?
|
| Genes, Retinoblastoma | 1 | 2008 | 92 | 0.020 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 104 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2002 | 3114 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2010 | 5658 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 734 | 0.020 |
Why?
|
| Genes, Synthetic | 1 | 1987 | 30 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2001 | 1695 | 0.020 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 123 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2008 | 200 | 0.020 |
Why?
|
| Melanoma | 1 | 2004 | 5596 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2008 | 460 | 0.020 |
Why?
|
| Lung | 1 | 1998 | 3287 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2002 | 2313 | 0.020 |
Why?
|
| Cattle | 1 | 1987 | 818 | 0.020 |
Why?
|
| Quinazolines | 1 | 2011 | 956 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2001 | 1420 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 908 | 0.020 |
Why?
|
| Mice, SCID | 2 | 2002 | 1825 | 0.020 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2005 | 6 | 0.020 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2005 | 25 | 0.020 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2004 | 36 | 0.020 |
Why?
|
| Adenovirus E4 Proteins | 1 | 2004 | 17 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 1260 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 336 | 0.010 |
Why?
|
| Exons | 1 | 2008 | 1388 | 0.010 |
Why?
|
| Chimerism | 1 | 2004 | 65 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2005 | 59 | 0.010 |
Why?
|
| Adenovirus E2 Proteins | 1 | 2004 | 3 | 0.010 |
Why?
|
| Artificial Gene Fusion | 1 | 2004 | 20 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2004 | 157 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 2004 | 54 | 0.010 |
Why?
|
| Gastrointestinal Agents | 1 | 2005 | 119 | 0.010 |
Why?
|
| Adenovirus E1 Proteins | 1 | 2003 | 6 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2005 | 240 | 0.010 |
Why?
|
| Vero Cells | 1 | 2004 | 124 | 0.010 |
Why?
|
| Helper Viruses | 1 | 2004 | 64 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 378 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 5868 | 0.010 |
Why?
|
| Cell Survival | 2 | 2003 | 3058 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 534 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2004 | 98 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1995 | 1072 | 0.010 |
Why?
|
| Ribosomes | 1 | 2004 | 166 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2008 | 1309 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 143 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2002 | 66 | 0.010 |
Why?
|
| Arabinofuranosyluracil | 1 | 2002 | 46 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 685 | 0.010 |
Why?
|
| Kinetics | 2 | 1995 | 2206 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 340 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 2101 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 2199 | 0.010 |
Why?
|
| Herpesviridae | 1 | 2002 | 43 | 0.010 |
Why?
|
| Integrin alphaV | 1 | 2001 | 24 | 0.010 |
Why?
|
| Formazans | 1 | 2001 | 5 | 0.010 |
Why?
|
| Spheroids, Cellular | 1 | 2002 | 220 | 0.010 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2001 | 90 | 0.010 |
Why?
|
| Immunologic Tests | 1 | 2001 | 35 | 0.010 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2003 | 333 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 690 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2002 | 335 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 784 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2001 | 286 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2002 | 388 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2004 | 775 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 10728 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 2419 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 494 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 2001 | 339 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2001 | 425 | 0.010 |
Why?
|
| Viruses | 1 | 2001 | 153 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1999 | 144 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 2134 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1999 | 117 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 1719 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1999 | 121 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 440 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 1580 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 574 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1999 | 235 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7233 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 1715 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 556 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1998 | 654 | 0.010 |
Why?
|
| Proteins | 1 | 2005 | 2030 | 0.010 |
Why?
|
| Mutation | 2 | 2011 | 15922 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 2657 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1723 | 0.010 |
Why?
|
| Ganciclovir | 1 | 1996 | 192 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 1213 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1996 | 181 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 153 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 1571 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 4965 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 7788 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 5692 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 714 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 2618 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 579 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1995 | 887 | 0.010 |
Why?
|
| Rabbits | 1 | 1995 | 1040 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 4105 | 0.010 |
Why?
|
| Male | 5 | 2001 | 128479 | 0.010 |
Why?
|
| Estrogens | 1 | 1995 | 804 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 5053 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1958 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2002 | 2192 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 4470 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 3463 | 0.000 |
Why?
|
| Survival Rate | 1 | 1999 | 12528 | 0.000 |
Why?
|
| Rats | 1 | 1995 | 6397 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 14639 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 7323 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 16243 | 0.000 |
Why?
|